Filing Details
- Accession Number:
- 0000899243-19-027509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-18 16:13:24
- Reporting Period:
- 2019-11-15
- Accepted Time:
- 2019-11-18 16:13:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1537917 | Tyme Technologies Inc. | TYME | Pharmaceutical Preparations (2834) | 453864597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1711342 | Steve Hoffman | C/O Tyme Technologies, Inc. 17 State Street - 7Th Floor New York NY 10004 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-15 | 10,000 | $1.03 | 26,492,748 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.05, inclusive. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.